ArticleDiabetes, obesity & metabolism2024

Comparative safety and cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in nursing homes.

Melissa R Riester et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.